Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor-induced Osteomalacia Disease Monitoring Program (TIO DMP)

NCT04783428 is registered in ClinicalTrials.gov with Ultragenyx Pharmaceutical Inc as lead sponsor.

NCT NCT04783428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04783428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor-induced Osteomalacia Disease Monitoring Program (TIO DMP)
Lead sponsor
Ultragenyx Pharmaceutical Inc
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 2022
Completion date
February 28, 2032
Enrollment
23 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

tumor-induced osteomalacia (tio)